578 related articles for article (PubMed ID: 29042262)
1. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil.
Silva J; Queiroz A; Moura I; Sousa RS; Guimarães LH; Machado PRL; Lessa M; Lago E; Wilson ME; Schriefer A
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006015. PubMed ID: 29095818
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
4. Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms.
Queiroz A; Sousa R; Heine C; Cardoso M; Guimarães LH; Machado PR; Carvalho EM; Riley LW; Wilson ME; Schriefer A
J Clin Microbiol; 2012 Dec; 50(12):4028-34. PubMed ID: 23035200
[TBL] [Abstract][Full Text] [Related]
5. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
[TBL] [Abstract][Full Text] [Related]
6. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.
Souza AS; Giudice A; Pereira JM; Guimarães LH; de Jesus AR; de Moura TR; Wilson ME; Carvalho EM; Almeida RP
BMC Infect Dis; 2010 Jul; 10():209. PubMed ID: 20633260
[TBL] [Abstract][Full Text] [Related]
7. Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.
Guimarães LH; Queiroz A; Silva JA; Silva SC; Magalhães V; Lago EL; Machado PR; Bacellar O; Wilson ME; Beverley SM; Carvalho EM; Schriefer A
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005100. PubMed ID: 27906988
[TBL] [Abstract][Full Text] [Related]
8. Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.
Schriefer A; Schriefer AL; Góes-Neto A; Guimarães LH; Carvalho LP; Almeida RP; Machado PR; Lessa HA; de Jesus AR; Riley LW; Carvalho EM
Infect Immun; 2004 Jan; 72(1):508-14. PubMed ID: 14688132
[TBL] [Abstract][Full Text] [Related]
9. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
Parasite; 2017; 24():34. PubMed ID: 28959938
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil.
Fernandes AC; Pedroso RB; de Mello TF; Donatti L; Venazzi EA; Demarchi IG; Aristides SM; Lonardoni MV; Silveira TG
Exp Parasitol; 2016 Aug; 167():83-93. PubMed ID: 27181585
[TBL] [Abstract][Full Text] [Related]
11. GENOTYPE CHARACTERIZATION OF Leishmania (Viannia) braziliensis ISOLATED FROM HUMAN AND CANINE BIOPSIES WITH AMERICAN CUTANEOUS LEISHMANIASIS.
Ferreira LT; Gomes AH; Pereira-Chioccola VL
Rev Inst Med Trop Sao Paulo; 2015; 57(3):257-62. PubMed ID: 26200968
[TBL] [Abstract][Full Text] [Related]
12. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
Arevalo J; Ramirez L; Adaui V; Zimic M; Tulliano G; Miranda-Verástegui C; Lazo M; Loayza-Muro R; De Doncker S; Maurer A; Chappuis F; Dujardin JC; Llanos-Cuentas A
J Infect Dis; 2007 Jun; 195(12):1846-51. PubMed ID: 17492601
[TBL] [Abstract][Full Text] [Related]
13. Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru.
Adaui V; Maes I; Huyse T; Van den Broeck F; Talledo M; Kuhls K; De Doncker S; Maes L; Llanos-Cuentas A; Schönian G; Arevalo J; Dujardin JC
Infect Genet Evol; 2011 Dec; 11(8):1873-80. PubMed ID: 21871584
[TBL] [Abstract][Full Text] [Related]
14. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.
Guimarães LH; Machado PR; Lago EL; Morgan DJ; Schriefer A; Bacellar O; Carvalho EM
Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):712-5. PubMed ID: 19481233
[TBL] [Abstract][Full Text] [Related]
15. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
Torres DC; Ribeiro-Alves M; Romero GA; Dávila AM; Cupolillo E
Acta Trop; 2013 May; 126(2):132-41. PubMed ID: 23416123
[TBL] [Abstract][Full Text] [Related]
16. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes.
Torres DC; Adaui V; Ribeiro-Alves M; Romero GA; Arévalo J; Cupolillo E; Dujardin JC
Infect Genet Evol; 2010 Aug; 10(6):727-33. PubMed ID: 20478409
[TBL] [Abstract][Full Text] [Related]
17. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.
Correa-Cárdenas CA; Pérez J; Patino LH; Ramírez JD; Duque MC; Romero Y; Cantillo-Barraza O; Rodríguez O; Alvarado MT; Cruz C; Méndez C
BMC Infect Dis; 2020 Dec; 20(1):938. PubMed ID: 33297972
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony.
Adaui V; Schnorbusch K; Zimic M; Gutiérrez A; Decuypere S; Vanaerschot M; DE Doncker S; Maes I; Llanos-Cuentas A; Chappuis F; Arévalo J; Dujardin JC
Parasitology; 2011 Feb; 138(2):183-93. PubMed ID: 20678296
[TBL] [Abstract][Full Text] [Related]
19. The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved.
Medina LS; Souza BA; Queiroz A; Guimarães LH; Lima Machado PR; M Carvalho E; Wilson ME; Schriefer A
PLoS One; 2016; 11(9):e0163284. PubMed ID: 27648939
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.
Lago J; Silva JA; Borja L; Fraga DBM; Schriefer A; Arruda S; Lago E; Carvalho EM; Bacellar O
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007532. PubMed ID: 31310601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
